Profile
| Metric | Value |
|---|---|
| Full Name | ImmunityBio, Inc. |
| Ticker | NASDAQ: IBRX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | immunitybio.com |
| Employees | 671 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $6.05 | |
| Price, 1D Change | +7.27% | |
| $6B | ||
| - | ||
| - | ||
| 1.49 | ||
| $15M | ||
| Revenue, 1Y Change | +2,270.58% | |
| -$0.62 | ||
| EPS, 1Y Change | +46.02% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | NK | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.62 | ||
| EPS Estimate | -$0.40 | |
| EPS Est. Change | +34.84% | |
| $14.75M | ||
| Revenue Estimate | $112.82M | |
| Revenue Est. Change | +665.15% | |
| Current Price | $6.05 | |
| Price Target | - | $9.00 |
| Price Tgt. Change | - | +48.76% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.93 | -$1.15 | -23.29% | |
| -$0.67 | -$0.62 | +7.63% | |
| -$0.40 | N/A | +34.84% | |
| -$0.26 | N/A | +58.52% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $510.00K | $622.00K | +21.96% | |
| $21.23M | $14.75M | -30.54% | |
| $112.82M | N/A | +665.15% | |
| $214.64M | N/A | +1,355.69% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $6.05 | |
| $2.77 | ||
| SMA 200 vs Price | -54.16% | |
| $3.46 | ||
| SMA 50 vs Price | -42.81% | |
| 1.49 | ||
| $0.64 | ||
| 63.47 | ||
| 78.94% | ||
| 96.03% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $14.75M | ||
| -$0.62 | ||
| -$2.81M | ||
| -19.05% | ||
| -$344.18M | ||
| -2,334.23% | ||
| -$413.65M | ||
| -2,805.32% | ||
| -$326.63M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -1.61 | ||
| 3.36 | ||
| 3.21 | ||
| - | ||
| 5 | ||
| -10.76 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 72.18 | ||
| -11.37 | ||
| -26.79 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$489.10M | ||
| $149.81M | ||
| $382.93M | ||
| $184.59M | ||
| $871.06M | ||
| $54.94M | ||
| $789.82M | ||
| $8.71M | ||
| $6.73M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $428.31M | ||
| $341.37M | ||
| $17.55M | ||
| $0.00 | ||
| $17.55M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$391.24M | ||
| -$12.25M | ||
| $281.63M | ||
| $6.89M | ||
| -$398.12M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| D. Boral Capital | → | |
| BTIG | → | |
| Piper Sandler | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| Jefferies | → | |
| D. Boral Capital | → |
Analyst sentiment
Institutional ownership
Screeners with IBRX
FAQ
What is the ticker symbol for ImmunityBio, Inc.?
The ticker symbol for ImmunityBio, Inc. is NASDAQ:IBRX
Does ImmunityBio, Inc. pay dividends?
No, ImmunityBio, Inc. does not pay dividends
What sector is ImmunityBio, Inc. in?
ImmunityBio, Inc. is in the Healthcare sector
What industry is ImmunityBio, Inc. in?
ImmunityBio, Inc. is in the Biotechnology industry
What country is ImmunityBio, Inc. based in?
ImmunityBio, Inc. is headquartered in United States
When did ImmunityBio, Inc. go public?
ImmunityBio, Inc. initial public offering (IPO) was on July 28, 2015
Is ImmunityBio, Inc. in the S&P 500?
No, ImmunityBio, Inc. is not included in the S&P 500 index
Is ImmunityBio, Inc. in the NASDAQ 100?
No, ImmunityBio, Inc. is not included in the NASDAQ 100 index
Is ImmunityBio, Inc. in the Dow Jones?
No, ImmunityBio, Inc. is not included in the Dow Jones index
When was ImmunityBio, Inc. last earnings report?
ImmunityBio, Inc.'s most recent earnings report was on November 10, 2025
When does ImmunityBio, Inc. report earnings?
The next expected earnings date for ImmunityBio, Inc. is March 2, 2026
Data Sources & References
- IBRX Official Website immunitybio.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1326110/000132611025000139/0001326110-25-000139-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1326110/000132611025000033/0001326110-25-000033-index.htm
- IBRX Profile on Yahoo Finance finance.yahoo.com/quote/IBRX
- IBRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ibrx